YARROW BIOSCIENCE, INC. Operating Lease Liability
YARROW BIOSCIENCE, INC. (YARW) had Operating Lease Liability of $99.00 thousand as of 2024-12-31, per its S-4/A filed 2026-06-03.
Financial Statements › Balance Sheet › Liabilities
us-gaap:OperatingLeaseLiability · last filed 2026-06-03
- 2024-12-31: Operating Lease, Liability $99.00K.
- 2023-12-31: Operating Lease, Liability $214.00K.
- 2023-10-01: Operating Lease, Liability $300.00K.
- 2023-09-30: Operating Lease, Liability $0.00.
| Period end | Operating Lease, Liability | Operating Lease, Liability as first filed |
|---|---|---|
| 2024-12-31 | $99.00K S-4/A · filed 2026-06-03 | |
| 2023-12-31 | $214.00K 10-K · filed 2025-03-06 | |
| 2023-10-01 | $300.00K S-4/A · filed 2026-06-03 | |
| 2023-09-30 | $0.00 10-Q · filed 2023-11-13 | |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $0.00 10-K · filed 2024-03-01 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-12 | |
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $349.00K 10-K · filed 2022-03-17 | |
| 2021-09-30 | $1.05M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $1.25M 10-Q · filed 2021-08-12 | |
| 2021-03-31 | $1.43M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $1.61M 10-K · filed 2022-03-17 | |
| 2020-09-30 | $2.19M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $2.55M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $1.74M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.75M 10-K · filed 2021-03-04 | $700.00K 10-K · filed 2020-03-03 |
| 2019-09-30 | $741.00K 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $715.00K 10-Q · filed 2019-08-01 | |
| 2019-03-31 | $684.00K 10-Q · filed 2019-05-02 | |
| 2019-03-13 | $700.00K 10-K · filed 2024-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B |